Development and validation of a web-based patient decision aid for immunotherapy for patients with metastatic melanoma: study protocol for a multicenter randomized trial
Patients with metastatic melanoma and their physicians are confronted with a complex decision regarding first-line therapy. Risks and benefits vary considerably between various treatment options. With this in mind, we aim to develop and evaluate a patient decision aid (PtDA) to inform patients about...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
20 April 2021
|
| In: |
Trials
Year: 2021, Volume: 22, Pages: 1-11 |
| ISSN: | 1468-6694 |
| DOI: | 10.1186/s13063-021-05234-4 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13063-021-05234-4 |
| Author Notes: | Pia Grabbe, Kathrin M. Gschwendtner, Imad Maatouk, Sophia B. Strobel, Martin Salzmann, Julia Bossert, Wolfgang Eich, Beate Wild, Friedegund Meier, Jessica C. Hassel, and Christiane Bieber |
| Summary: | Patients with metastatic melanoma and their physicians are confronted with a complex decision regarding first-line therapy. Risks and benefits vary considerably between various treatment options. With this in mind, we aim to develop and evaluate a patient decision aid (PtDA) to inform patients about the risks and benefits of treatment options, namely, immunotherapy as monotherapy, immunotherapy as combination therapy, and treatment with BRAF/MEK inhibitors. We aim to test whether the use of this PtDA before medical consultation will increase patients’ knowledge of treatment options and thus promote shared decision-making (SDM) and patient decision satisfaction. |
|---|---|
| Item Description: | Gesehen am 10.06.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1468-6694 |
| DOI: | 10.1186/s13063-021-05234-4 |